AR-V7: What We Know, What We Think - Christopher Evans

Christopher Evans presents an overview of AR-V7 summarizing the recent literature.  (Presented in 6:36)

Christopher Evans, MD is Professor and Chair Department Urology, UC Davis.  Dr. Evans' practice is dedicated to the management of patients with urologic malignancies. He works with medical oncologists and radiation oncologists to provide multimodal approaches to cancer therapy.  Dr. Evans' research laboratory focuses on prostate cancer; specifically, mechanisms signaling the androgen receptor to activate prostate cancer growth and progression following castration. His laboratory has developed models to study this and has identified novel mechanisms that activate the androgen receptor.  His laboratory work has tested new agents and brought them from bench studies to animal models to clinical trials. His surgical expertise includes robotic assisted laparoscopic radical prostatectomy with nerve sparing, complex renal surgery to include partial nephrectomy and vena cava thrombectomy, cystectomy with extended pelvic lymph node dissection and urinary diversion with orthotopic neobladders.  Dr. Evans also has expertise in treating patients with metastatic testicular cancer and performing retroperitoneal lymph node dissection in post chemotherapy patients.

Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.